Provention Bio, Inc. (PRVB) Income Annual - Discounting Cash Flows
PRVB
Provention Bio, Inc.
PRVB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing 2023-03-29 2023-03-29 2022-02-24 2021-02-25 2020-03-12 2019-03-19 2017-12-31
Revenue 12.89 12.89 1.4 0 0 0 0
Cost of Revenue 0.512 0.512 0 0 0 0 0
Gross Profit 12.38 12.38 1.4 0 0 0 0
Operating Expenses 140.5 140.5 117 99.69 44.37 26.81 9.14
Research & Development 75.8 75.8 69.63 66.36 36.36 22.65 7.68
Selling, General and Administrative 64.11 64.11 47.35 33.33 8.01 4.17 1.46
Other Operating Expenses 0.627 0.627 0 0 0 0 0
Operating Income -128.2 -128.2 -115.6 -99.69 -44.37 -26.81 -9.14
Net Non-Operating Interest 1.06 1.2 0.146 0.583 1.09 0.669 0.132
Interest Income 2.24 2.24 0.146 0.583 1.09 0.669 0.132
Interest Expense 1.18 1.04 0 0 0 0 0
Equity & Other Income/(Expense) 0.146 0 0 0 0 -0.52 -0.125
Income Before Tax -127 -127 -115.4 -99.1 -43.28 -26.66 -9.13
Income Tax Expense -13.98 -13.39 -1 -0.523 -1.09 -0.187 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
Net Income -113 -113.6 -114.4 -98.58 -42.2 -26.48 -9.13
Depreciation and Amortization 3.27 3.47 0.387 0.033 -0.016 0.149 0.007
EBITDA -124.9 -124.7 -115.2 -99.65 -44.39 -26.66 -9.13
Earnings Per Share (EPS) -1.6 -1.52 -1.81 -1.88 -1.04 -1.18 -0.27
Diluted Earnings Per Share -1.6 -1.52 -1.81 -1.88 -1.04 -1.18 -0.27
Weighted Average Shares Outstanding 74.72 74.72 63.1 52.46 40.75 22.44 33.88
Diluted Weighted Average Shares Outstanding 74.72 74.72 63.1 52.46 40.75 22.44 33.88
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program